FilingReader Intelligence
WuXi AppTec reports strong first quarter, boosts share repurchase
April 29, 2025 at 05:24 AM UTC•By FilingReader AI
WuXi AppTec (HKEX:2359) announced robust first-quarter results for 2025, reporting a 20.96% increase in revenue to RMB9.65 billion, driven primarily by strong performance in its chemistry drug CRDMO, biology discovery, preclinical testing, and clinical research services. Net profit attributable to owners surged 89.06% to RMB3.67 billion.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when WuXi AppTec Co publishes news
Free account required • Unsubscribe anytime